Back to Search
Start Over
Iovance Biotherapeutics to Present at Upcoming Conferences in November
- Source :
- GlobeNewswire. October 28, 2020
- Publication Year :
- 2020
-
Abstract
- SAN CARLOS, Calif., Oct 28, 2020 (GLOBE NEWSWIRE via COMTEX) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today announced that the [...]
- Subjects :
- United States. Food and Drug Administration -- Planning
Credit Suisse Group AG -- Forecasts and trends
Cancer treatment -- Forecasts and trends
Business planning -- Forecasts and trends
Immunotherapy -- Forecasts and trends
Financial services -- Forecasts and trends
Pembrolizumab -- Forecasts and trends
T cells -- Forecasts and trends
Company business planning
Financial services industry
Market trend/market analysis
Banking, finance and accounting industries
Business
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- GlobeNewswire
- Publication Type :
- News
- Accession number :
- edsgcl.639672530